Morning Market Movers
October 22, 2014 at 09:42 AM EDT
Regulus Therapeutics (NASDAQ: RGLS) shares climbed 94.39% to $13.16 following the announcement of positive RG-101 study data. Unisys ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.